Premium
Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: Cancer association of annexin A3
Author(s) -
Wozny Wojciech,
Schroer Klaus,
Schwall Gerhard P.,
Poznanović Slobodan,
Stegmann Werner,
Dietz Klaus,
Rogatsch Hermann,
Schaefer Georg,
Huebl Heidi,
Klocker Helmut,
Schrattenholz André,
Cahill Michael A.
Publication year - 2007
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/pmic.200600646
Subject(s) - prostate cancer , pathology , biology , stromal cell , staining , prostate , cancer , intraepithelial neoplasia , stroma , immunohistochemistry , cancer research , medicine , genetics
A differential quantitative protein expression study, comparing matched prostate cancerous and benign tissues from 31 patients, revealed proteins newly associated with prostate cancer. Average effects for 17 proteins whose abundance was significantly different ( p <0.01) across patients ranged from 1.5‐ to 6.1‐fold, and included a number of known cancer markers. The most differentially abundant proteins between cancer and benign samples were isopeptidase T, serum amyloid P (SAP), annexin A3 (ANXA3) and mitochondrial enoyl coenzyme‐A hydratase. SAP is restricted to stroma in healthy tissue, and the lower abundance in tumours may be explained by the reduced stromal content. ANXA3 is present in healthy epithelial cells, exhibits strong staining in precancerous prostatic intraepithelial neoplasia, and is relatively less abundant in individual tumour cells of increasing Gleason pattern (GP), despite exhibiting higher overall tissue abundance in tumours. ANXA3 staining was predominantly cytoplasmic, yet nuclear localization was also observed. Strongly staining single cells, possibly phagocytes, were interspersed in highly dedifferentiated GP5 tumour areas among tumour cells without measurable ANXA3. Local recurrent androgen ablation therapy‐resistant tumours exhibit heterogenous low levels of ANXA3 staining. Results are discussed focussing on the potential implications for tumour tissues.